Helsen Pharma & Consulting: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Helsen Pharma & Consulting
Largest movements
- Receivables within one year +€11,795
new in 2025: €11,795
- Cash -€3,692
down €3,692 (-41.7%), from €8,846 to €5,154
mainly Debts after one year (-€18,589) and Receivables within one year (-€11,795)
- Reserves +€22,350
up €22,350 (+160%), from €13,944 to €36,294
- Debts after one year -€18,589
down €18,589 (-12.2%), from €152,406 to €133,817
- Tax, wage and social debts +€7,721
up €7,721 (+69.5%), from €11,112 to €18,833
of which Taxes: +€7,696
- Other debts -€4,723
down €4,723 (-8.9%), from €53,353 to €48,630
- Financial charges -€7,285
down €7,285 (-47.9%), from €15,217 to €7,932
- Gross operating margin +€2,195
up €2,195 (+6.3%), from €34,636 to €36,831
- Taxes +€1,352
up €1,352 (+26.6%), from €5,090 to €6,442
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €261,604 | €269,729 | +€8,125 | +3.1% |
| Fixed assets | 21/28 | €252,000 | €252,000 | = | 0.0% |
| Financial fixed assets | 28 | €252,000 | €252,000 | = | 0.0% |
| Current assets | 29/58 | €9,604 | €17,729 | +€8,125 | +84.6% |
| Amounts receivable within one year | 40/41 | - | €11,795 | +€11,795 | |
| Trade receivables | 40 | - | €11,795 | +€11,795 | |
| Cash at bank and in hand | 54/58 | €8,846 | €5,154 | -€3,692 | -41.7% |
| Deferred charges and accrued income | 490/1 | €758 | €780 | +€22 | +2.9% |
| Total equity and liabilities | 10/49 | €261,604 | €269,729 | +€8,125 | +3.1% |
| Equity | 10/15 | €23,944 | €46,294 | +€22,350 | +93.3% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Reserves | 13 | €13,944 | €36,294 | +€22,350 | +160% |
| Distributable reserves | 133 | €13,944 | €36,294 | +€22,350 | +160% |
| Amounts payable | 17/49 | €237,660 | €223,435 | -€14,226 | -6.0% |
| Amounts payable after more than one year | 17 | €152,406 | €133,817 | -€18,589 | -12.2% |
| Financial debts | 170/4 | €152,406 | €133,817 | -€18,589 | -12.2% |
| Amounts payable within one year | 42/48 | €83,794 | €88,100 | +€4,306 | +5.1% |
| Current portion of amounts payable after more than one year | 42 | €17,890 | €18,589 | +€699 | +3.9% |
| Trade debts | 44 | €1,438 | €2,048 | +€609 | +42.4% |
| Suppliers | 440/4 | €1,438 | €2,048 | +€609 | +42.4% |
| Taxes, remuneration and social security | 45 | €11,112 | €18,833 | +€7,721 | +69.5% |
| Taxes | 450/3 | €8,927 | €16,623 | +€7,696 | +86.2% |
| Remuneration and social security | 454/9 | €2,185 | €2,210 | +€25 | +1.2% |
| Other amounts payable | 47/48 | €53,353 | €48,630 | -€4,723 | -8.9% |
| Accrued charges and deferred income | 492/3 | €1,460 | €1,517 | +€57 | +3.9% |
| Other operating charges | 640/8 | €386 | €183 | -€203 | -52.6% |
| Gross operating margin | 9900 | €34,636 | €36,831 | +€2,195 | +6.3% |
| Operating profit (loss) | 9901 | €34,250 | €36,648 | +€2,398 | +7.0% |
| Financial income | 75/76B | - | €77 | +€77 | |
| Recurring financial income | 75 | - | €77 | +€77 | |
| Financial charges | 65/66B | €15,217 | €7,932 | -€7,285 | -47.9% |
| Recurring financial charges | 65 | €15,217 | €7,932 | -€7,285 | -47.9% |
| Profit (loss) for the period before taxes | 9903 | €19,034 | €28,793 | +€9,759 | +51.3% |
| Income taxes | 67/77 | €5,090 | €6,442 | +€1,352 | +26.6% |
| Profit (loss) for the period | 9904 | €13,944 | €22,350 | +€8,407 | +60.3% |
| Profit (loss) for the period to be appropriated | 9905 | €13,944 | €22,350 | +€8,407 | +60.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.